Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort

British Journal of Cancer

Volumn 104, Issue 9, 2011, Pages 1511-1516

  Abnet, C C ^a   Zheng, W ^b,c   Ye, W ^d   Kamangar, F ^e   Ji, B T ^a   Persson, C ^a   Yang, G ^b   Li, H L ^f   Rothman, N ^a   Shu, X O ^b,c   Gao, Y T ^f   Chow, W H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MORGAN STATE UNIVERSITY   (United States)

^f SHANGHAI CANCER INSTITUTE   (China)

Author keywords

China; cohort; gastric cancer; Helicobacter pylori; pepsinogens

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER;

ADULT; AGED; ANTIBODIES, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LINEAR MODELS; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PEPSINOGENS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WOMEN'S HEALTH;

EID: 79955484244     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.77     Document Type: Article

References (34)

1. Andrew A, Wyatt JI, Dixon MF (1994) Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 25(4): 317-322 (Pubitemid 24327126)
2. Brenner H, Rothenbacher D, Weck MN (2007) Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 121(12): 2782-2786 (Pubitemid 350136427)
3. Correa P (1992) Human gastric carcinogenesis: a multistep and multi-factorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52(24): 6735-6740 (Pubitemid 23006271)
4. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD (2005) Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 9(5): 718-725 (Pubitemid 40603013)
5. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302(6788): 1302-1305
6. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M (1995) Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 86(1): 64-71
7. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR (2006a) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98(20): 1445-1452 (Pubitemid 44605589)
8. Kamangar F, Diaw L, Wei W-Q, Abnet CC, Wang G-Q, Roth MJ, Liu B, Lu N, Giffen C, Qiao Y-L, Dawsey SM (2008) Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 124(2): 456-460
9. Kamangar F, Dores GM, Anderson WF (2006b) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14): 2137-2150 (Pubitemid 46655601)
10. Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, Perez-Perez GI, Abnet CC, Zhao P, Mark SD, Taylor PR, Dawsey SM (2007) Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96(1): 172-176 (Pubitemid 46094658)
11. Kimura K (1972) Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63(4): 584-592
12. Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H (2005) Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol 11(7): 1032-1036 (Pubitemid 40347758)
13. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9(3): 279-287 (Pubitemid 351722947)
14. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J (2001) Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 10(2): 107-112 (Pubitemid 32172428)
15. Nomura AM, Kolonel LN, Miki K, Stemmermann GN, Wilkens LR, Goodman MT, Perez-Perez GI, Blaser MJ (2005) Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 191(12): 2075-2081 (Pubitemid 40800578)
16. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, Doi Y, Shikata K, Yonemoto K, Shirota T, Matsumoto T, Iida M (2006) The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 163(7): 629-637
17. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108 (Pubitemid 40372904)
18. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325(16): 1127-1131
19. Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD (1993) Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2(5): 461-466
20. Ren JS, Kamangar F, Qiao YL, Taylor PR, Liang H, Dawsey SM, Liu B, Fan JH, Abnet CC (2009) Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 58(5): 636-642
21. Samloff IM, Taggart RT (1987) Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med 10(3): 215-221 (Pubitemid 17113564)
22. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI (1982) Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 83(1 Part 2): 204-209 (Pubitemid 12121596)
23. Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K, Kawata H, Tokumaru K, Kojima T, Seki M, Ido K, Fujioka T (1998) Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 93(4): 569-573 (Pubitemid 29081004)
24. Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY (2005) Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 115(3): 463-469 (Pubitemid 40663752)
25. Sipponen P, Graham DY (2007) Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 42(1): 2-10 (Pubitemid 46033039)
26. Stemmermann GN, Samloff IM, Nomura AM, Heilbrun LK (1987) Serum pepsinogens I and II and stomach cancer. Clin Chim Acta 163(2): 191-198 (Pubitemid 17046077)
27. Sugano K (2008) Gastric cancer: pathogenesis, screening, and treatment. Gastrointest Endosc Clin N Am 18(3): 513-522, ix
28. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M (2005) Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54(6): 764-768 (Pubitemid 40732089)
29. Weck MN, Brenner H (2006) Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 15(6): 1083-1094
30. Weck MN, Stegmaier C, Rothenbacher D, Brenner H (2007) Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 26(6): 879-887 (Pubitemid 47346707)
31. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O (2004) Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96(5): 388-396 (Pubitemid 38351300)
32. You WC, Blot WJ, Zhang L, Kneller RW, Li JY, Jin ML, Chang YS, Zeng XR, Zhao L, Fraumeni Jr JF (1993) Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer. Cancer Epidemiol Biomarkers Prev 2(2): 113-117
33. Yuan JM, Yu MC, Xu WW, Cockburn M, Gao YT, Ross RK (1999) Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort. Cancer Epidemiol Biomarkers Prev 8(7): 621-624 (Pubitemid 29337323)
34. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, Shu XO, Gao YT (2005) The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162(11): 1123-1131 (Pubitemid 41746625)